Anti-CD22 (clone I1C1R22-26) SynExpress SV-BF-L/T-E CD8+ T Cells

CAT#: ITS-1124-CR41
Clone: I1C1R22-26
Host: Human
Cell Source: Modified CD8+ T cells
Species Reactivity: Human
Connector Fragments: SV40-BFP-LEF/TCF-EcoRI
Carrier Type: HBV
Description
This product utilizes CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD22 ( clone I1C1R22-26). We employs the HBV (SV40-BFP-LEF/TCF-EcoRI) vector components and the SynExpress system of the introns Knockout/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD22
Clone
I1C1R22-26
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
SV40
Effector Gene
LEF/TCF
Insertion Sites
EcoRI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.89
Cell Culture
Suspension Culture
Target
CD22
Alternative Names
CD22; SIGLEC-2; SIGLEC2; CD22 molecule
Gene ID
P16871(Human)
UniProt ID
933(Human)
Format
Lyophilized/Liquid
Shipping
All cell products are transported using dry ice, or specialized refrigerated containers to ensure that their temperature remains within an appropriate range. For cell products that are particularly sensitive to temperature, transportation must be carried out in liquid nitrogen tanks to ensure the quality and viability of the products.
Handling Advice
Handle cells in a sterile environment to prevent contamination. Use aseptic techniques when transferring to new media or containers. Follow biosafety regulations for disposing of cell waste.
Storage
Keep cell products in the designated temperature range (usually liquid nitrogen or -80°C) to maintain viability.
For Research Use Only | Not For Clinical Use
Online Inquiry